CACO-Bay Area Quarterly seminar luncheons
Our popular seminar luncheons are held quarterly, normally from
11:00am to 1:00pm on Fridays. The venue is Crwone Plaza Hotel in Foster City,
which is centrally located in the Bay Area and readily accessible from major
highways such as 101 and 92. Thanks to the generous financial support from
close to 30 vendors each time, we have been able to provide the luncheons to our
members free of charge. The attendance has been overwhelming,
with ~300 scientists attending each time.
2010 Seminar
Luncheon Dates:
-
Feb. 19: Towards a Standardized
Metabolomics Repository (Jointly with Bay Area Bioinformatics Forum)
(Professor Oliver Fiehn, UC Davis)
-
May 21: Ligand-Binding Mass Spectrometry
to Investigate Protein Drug Biotransformation, Direct Candidate Selection,
and Corroborate Immunoassays (Michael Hall, Ph.D., Amgen)
-
Sept. 17: Utility of nanowire technology
in oral drug delivery (Professor Tejle Desai, UCSF)
-
Dec. 3: Excipients in drug formulation
(Jointly with AAPS-BADG)
Past seminar
luncheons:
-
Dec 04, 2009: Use of Nano Particle Technology to Enhance Performance of
Pharmaceutical Products (Niels Ryde,
Ph.D.,
Elan Drug Technologies)
-
Sept. 18, 2009: Drug Physical Form and its Importance in Drug Candidate
Development (Michael Brandl,
Ph.D.,
Roche)
-
May 15, 2009:
Prodrugs – How, when and why
(Matthew Wright,
Ph.D.;
Adrian Ray,
Ph.D.,
Gilead)
-
Feb. 13, 2009:
Strategies to Evaluate the Blood-Brain Barrier in Drug Discovery
and Development (Xingrong Liu, Ph.D., Roche)
-
Dec. 05, 2008: Metabolite
identification in drug discovery and development. Are we getting
our money's worth? (Cornelis Hop, Ph.D.,Genentech)
-
Sept. 19, 2008: Site Seeing in
the World of Regulatory Affairs (Senior Manager, Genentech)
-
May 23, 2008: Preclinical Toxicology Studies:
Considerations in the Design, Implementation and Interpretation
(Brian Rogers, Ph.D., Pacific BioDevelopment)
-
Mar. 21, 2008: Accelerator Mass Spectrometry and
Microdosing (John Vogel, Ph.D.)
-
Nov. 30, 2007:
Joint BAAC-BAPK/PD meeting: Utility of PK/PD Modeling in Drug development
(Emil Samara, PhD, PharmaPolaris)
-
Sept. 21, 2007:
Improving Medicines Through Active Transport (Feng
Xu, Ph.D., Xenoport)
-
May 18, 2007: Bioanalytical
Strategies for Antibody-Drug Conjugate Biopharmaceutical Development:
Immunoassays and LC-MS Assays (Surinder Kaur, Ph.D., Genentech)
-
Mar. 23, 2007:
Regulated Bioanalysis - Crystal City Revisit (Danlin Wu, Ph.D., Roche Palo Alto)
-
Dec. 01, 2006: The Value (or Non-value) of in vitro ADME Tools in
Picking the Perfect Drug Candidates (Mario Monshouwer, Ph.D.,
Roche Palo Alto)
-
Sept. 22, 2006: Hsiao Dee Lieu, M.D. (Portola
Pharmaceuticals), "Demystifying the Blackbox of Clinical Research and Development"
-
June 09, 2006: Kathryn Woodburn, Ph.D. (Affymax):
"Translational Preclinical Development"
-
Mar. 31, 2006: Professor Joe Pesek (San Jose State
University): "Recent Advances in Column Chemistry"
-
Dec. 09, 2005: John Wang, Ph.D. (Genentech):
"Pharmaceutics in Drug Development"
-
Sept. 16, 2005: Mark Grillo, Ph.D. (Amgen San Francisco), "Metabolic activation
and idiosyncratic drug toxicities"
-
May 20, 2005:
Ed Berger (Guidant), "Drug Eluting Stents and Stent Analysis"
-
Mar. 25:
May Lee, Ph.D. (Iconix), Gene Expression Changes induced by Drug Treatment:
Understanding Drug Off-target Effects and Drug Metabolism
-
Dec. 08, 2004:
Professor Philip Crews (UC San Cruz), The chemistry and art of wine making?
-
Sept. 17: 2004:
Ning Tang, Ph.D. (Agilent), Recent technological developments in proteomic
research
-
June 11, 2004:
Haihong Zhou, Ph.D. (Surromed), Global Differential Expression Profiling for
Metabolic Biomarker Discovery: Advances and Challenges?
-
Mar. 19, 2004:
Robert Cass (Theravance), Automation for today's Bioanalytical Laboratory
-- Are we doing all we can??
-
Dec. 2003:
Jim Zhang, Ph.D. (Affymax), Characterization of PEGylated peptide drugs?
-
Sept. 2003:
Michael Kernan, Ph.D. (Gilead), Application of Analytical Methods to
Pharmaceutical Development?
-
June 2003: Jim Bao, Ph.D. (Theravance), Capillary electrophoresis in
drug discovery and development?